BD names new chief scientific officer

Digital health pioneer to focus on external innovation

Franklin Lakes-based BD, also known as Becton, Dickinson and Co., named Joseph Smith as its senior vice president and chief scientific officer, effective immediately.

Smith has greater than 30 years’ experience in the digital health technology sector and will be primarily responsible for external innovation and BD’s technology roadmap to deliver transformative innovations that align to three irreversible forces driving the future of health care: smart connected care, the transition to new care settings and chronic disease. Smith will report to Elizabeth McCombs, executive vice president and chief technology officer for BD.

“Joe is a digital health pioneer who brings more than 30 years of experience to BD, with his life’s work focused on the intersection of medicine and technology,” McCombs said. “Digital technologies have transformed the world and our lives, and we see great potential to apply these technologies, helping health care professionals and organizations achieve better outcomes and patient experiences, while optimizing care delivery. Joe will help BD push the boundaries in digital health technologies that can accelerate smart connected care, enable the transition to new care settings and improve chronic disease.”

Smith joins BD from Digital Health Corp, a holding company where he served as president and CEO, responsible for the company’s strategy to invest in or acquire digital health and therapeutic technologies. He also served as president for a digital transformation consultancy, providing business, technology and clinical insight to medical device and diagnostics companies. During his career, Smith has held medical, scientific and technology leadership positions at multiple organizations, including Johnson & Johnson, Boston Scientific and the West Health Institute. He has also served as academic faculty at Washington University School of Medicine and Department of Biomedical Engineering.